
SolutionDx Inc. is a diagnostics platform company that leverages Artificial Intelligence and Machine Learning to deliver superior Point-of-Care diagnostic solutions, focusing on rapid, accurate, and connected triage tests for infectious diseases such as Tuberculosis, HIV, and COVID-19. Their proprietary platform includes Find™, a microfluidic test card; Xplora™, a smartphone-operated AI analysis tool; and Dxter™, a cloud-based data analytics platform. The company aims to decentralize diagnostic testing to improve access, reduce costs, and enable real-time data reporting, targeting high-burden infectious disease markets globally with regulatory approvals in Mexico, Indonesia, and Europe. Their products offer high sensitivity and specificity, are portable, equipment-free, and designed for remote and resource-limited settings, positioning SolutionDx as an innovative leader in rapid infectious disease diagnostics.

SolutionDx Inc. is a diagnostics platform company that leverages Artificial Intelligence and Machine Learning to deliver superior Point-of-Care diagnostic solutions, focusing on rapid, accurate, and connected triage tests for infectious diseases such as Tuberculosis, HIV, and COVID-19. Their proprietary platform includes Find™, a microfluidic test card; Xplora™, a smartphone-operated AI analysis tool; and Dxter™, a cloud-based data analytics platform. The company aims to decentralize diagnostic testing to improve access, reduce costs, and enable real-time data reporting, targeting high-burden infectious disease markets globally with regulatory approvals in Mexico, Indonesia, and Europe. Their products offer high sensitivity and specificity, are portable, equipment-free, and designed for remote and resource-limited settings, positioning SolutionDx as an innovative leader in rapid infectious disease diagnostics.